Table 1:
HIV-1 Seroconverters | HIV-1 Uninfected Controls | p-value† | |||||
---|---|---|---|---|---|---|---|
n | % | n | % | ||||
Baseline | n=8 | n=94 | |||||
Age‡ | 25 (22–31) | 24 (21–29) | 0.62 | ||||
Gender | |||||||
Cisgender male | 6 | 75 | 76 | 80.9 | 0.69 | ||
Transgender female | 2 | 25 | 18 | 19.2 | |||
Rectal GC/CT | |||||||
Negative | 2 | 25 | 53 | 56.4 | 0.14 | ||
Positive | 6 | 75 | 41 | 43.6 | |||
Syphilis | |||||||
Negative | 7 | 87.5 | 91 | 96.8 | 0.28 | ||
Positive | 1 | 12.5 | 3 | 3.2 | |||
Sexual partners last month‡ | 4.5 (2.5–5.5) | 6 (2.5–10) | 0.39 | ||||
RAI partners last month‡ | 4.5 (2.5–8) | 4 (2–7) | 0.71 | ||||
CRAI partners last month‡ | 2.5 (1–4) | 3 (1–4) | 0.93 | ||||
3-month follow-up | n=8 | n=89 | |||||
Rectal GC/CT | |||||||
Negative | 7 | 87.5 | 75 | 84.3 | 1.00 | ||
Positive | 1 | 12.5 | 14 | 15.7 | |||
Sexual partners‡ | 3 (0.5–3.5) | 2 (1–4) | 0.69 | ||||
RAI partners last month‡ | 2 (0.5–3) | 2 (1–3) | 0.79 | ||||
CRAI partners last month‡ | 0.5 (0–1.5) | 1 (0–2) | 0.71 | ||||
6-month follow-up | n=7 | n=88 | |||||
Rectal GC/CT | |||||||
Negative | 7 | 100 | 79 | 89.8 | 0.49 | ||
Positive | 0 | 0 | 9 | 10.2 | |||
Sexual partners last month‡ | 3 (0–4) | 2 (1–5) | 0.94 | ||||
RAI partners last month‡ | 3 (0–4) | 1 (0.5–3) | 0.72 | ||||
CRAI partners last month‡ | 0 (0–1) | 0 (0–1) | 0.29 | ||||
Month prior to seroconversion | n=8 | n=88 | |||||
Sexual partners‡ | 3 (0.5–3.5) | 2 (1–4) | 0.69 | ||||
RAI partners‡ | 2 (0.5–3) | 2 (1–3) | 0.79 | ||||
CRAI partners‡ | 1 (0–1.5) | 1 (0–2) | 0.93 |
Calculated using Fisher’s exact or Kruskal-Wallis tests
Median (interquartile range)
GC/CT = gonorrhea/chlamydia infection; RAI = receptive anal intercourse; CRAI = condomless receptive anal intercourse